ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
AT1 receptors mediate the effects of cold stress and amphetamine on neurocognitive performance.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Cognitive effects of methamphetamine and amphetamine withdrawal in rodents: a systematic review.Frontiers in psychology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Brain angiotensin II (Ang II) modulates catecholamine neurotransmission via its AT1 receptors (AT1-R) and plays a critical role in neurocognitive processes. We previously showed that amphetamine (Amph) exposure induced cognitive alterations, many times unmasked by further Amph or Ang II challenge administration. In this work, we aimed to evaluate whether Amph exposure modifies the future neurocognitive response to cold stress, an environmental cue, and the possible role of the AT1-R. Male Wistar rats received AT1-R blocker (Candesartan)/Vehicle from day 0 to 5, and Amph/Saline from day 6 to 10. After 7 days of withdrawal, the animals were exposed to a cold stress challenge (4 °C for 4 h) and tested for working and long-term memory. Cold stress reversed the Amph-induced working memory deficit, while previous Amph exposure blunted the interference of cold stress on long-term memory consolidation. Blood adrenaline and glucose levels were increased in the Amph-treated animals after cold stress and/or test exposure. Remarkably, the AT1-R blockade prevented all the alterations induced by Amph exposure and elicited by cold-challenge. Our results indicate that Amph-induced neuroadaptations exhibit a wide range of responses to a catecholamine-releasing stimuli, including pharmacological or non-pharmacological challenges, such as environmental conditions, involving the AT1-R.
Indexed as
Identifiers
41114797What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.